{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:07:21Z","timestamp":1786982841627,"version":"build-2736575974"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2024,4,9]],"date-time":"2024-04-09T00:00:00Z","timestamp":1712620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,9]],"date-time":"2024-04-09T00:00:00Z","timestamp":1712620800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nephrol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and objectives<\/jats:title>\n                    <jats:p>Atherosclerotic renal artery stenosis may cause hypertension, chronic kidney disease and heart failure, but large randomized control trials to date have shown no major additional benefit of renal revascularization over optimal medical management. However, these trials did not consider outcomes specifically in relation to clinical presentations. Given that atherosclerotic renal artery stenosis is a heterogenous condition, measures of success likely differ according to the clinical presentation. Our retrospective study objectives were to determine the effects of revascularization when applied to specific clinical presentations and after careful multi-disciplinary team review.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>All patients presenting to our centre and its referring hospitals with radiological findings of at least one renal artery stenosis\u2009&gt;\u200950% between January 2015 and January 2020 were reviewed at the renovascular multi-disciplinary team meeting with revascularization considered in accordance with international guidelines, notably for patients with anatomically significant renal artery stenosis, adequately sized kidney and presentations with any of; deteriorating kidney function, heart failure syndrome, or uncontrollable hypertension. Optimal medical management was recommended for all patients which included lipid lowering agents, anti-platelets and anti-hypertensives targeting blood pressure\u2009\u2264\u2009130\/80\u00a0mmHg. The effect of revascularization was assessed according to the clinical presentation; blood pressure and number of agents in those with renovascular hypertension, delta glomerular filtration rate in those with ischaemic nephropathy and heart failure re-admissions in those with heart failure syndromes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>During this 5-year period, 127 patients with stenosis\u2009\u2265\u200950% were considered by the multidisciplinary team,\u00a0with 57 undergoing revascularization (17 primarily for severe hypertension, 25 deteriorating kidney function, 6 heart failure syndrome and 9 for very severe anatomical stenosis). Seventy-nine\u00a0percent of all revascularized patients had a positive outcome specific to their clinical presentation, with 82% of those with severe hypertension improving blood pressure control, 72% with progressive ischaemic nephropathy having attenuated GFR decline, and no further heart failure admissions in those with heart failure. Seventy-eight percent of patients revascularized for high grade stenosis alone had better blood pressure control with 55% also manifesting renal functional benefits.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Multi-disciplinary team discussion successfully identified a group of patients more likely to benefit from revascularization based on 3 key factors: clinical presentation, severity of the renal artery lesion and the state of the kidney beyond the stenotic lesion. In this way, a large proportion of patients can clinically improve after revascularization if their outcomes are considered according to the nature of their clinical presentation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical Abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1007\/s40620-024-01902-1","type":"journal-article","created":{"date-parts":[[2024,4,9]],"date-time":"2024-04-09T12:02:05Z","timestamp":1712664125000},"page":"1093-1105","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Improving outcomes in atherosclerotic renovascular disease: importance of clinical presentation and multi-disciplinary review"],"prefix":"10.1093","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6223-5601","authenticated-orcid":false,"given":"\u00c1ine M.","family":"de Bhailis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Lake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantina","family":"Chrysochou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darren","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajkumar","family":"Chinnadurai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip A.","family":"Kalra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,4,9]]},"reference":[{"issue":"1","key":"1902_CR1","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1111\/j.1523-1755.2005.00406.x","volume":"68","author":"PA Kalra","year":"2005","unstructured":"Kalra PA, Guo H, Kausz AT, Gilbertson DT, Liu J, Chen SC et al (2005) Atherosclerotic renovascular disease in United States patients aged 67 years or older: risk factors, revascularization, and prognosis. Kidney Int 68(1):293\u2013301","journal-title":"Kidney Int"},{"issue":"7","key":"1902_CR2","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1097\/HJH.0b013e328329bbf4","volume":"27","author":"Q de Mast","year":"2009","unstructured":"de Mast Q, Beutler JJ (2009) The prevalence of atherosclerotic renal artery stenosis in risk groups: a systematic literature review. J Hypertens 27(7):1333\u20131340","journal-title":"J Hypertens"},{"issue":"12","key":"1902_CR3","doi-asserted-by":"publisher","first-page":"840","DOI":"10.7326\/0003-4819-150-12-200906160-00119","volume":"150","author":"L Bax","year":"2009","unstructured":"Bax L, Woittiez AJJ, Kouwenberg HJ, Mali WPTM, Buskens E, Beek FJA et al (2009) Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial. Ann Intern Med 150(12):840\u2013848","journal-title":"Ann Intern Med"},{"issue":"20","key":"1902_CR4","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1056\/NEJMoa0905368","volume":"361","author":"K Wheatley","year":"2009","unstructured":"Wheatley K, Ives N, Gray R, Kalra PA, Moss JG et al (2009) Revascularization versus medical therapy for renal-artery stenosis. N Engl J Med 361(20):1953\u20131962","journal-title":"N Engl J Med"},{"issue":"1","key":"1902_CR5","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1056\/NEJMoa1310753","volume":"370","author":"CJ Cooper","year":"2014","unstructured":"Cooper CJ, Murphy TP, Cutlip DE, Jamerson K, Henrich W, Reid DM et al (2014) Stenting and medical therapy for atherosclerotic renal-artery stenosis. N Engl J Med 370(1):13\u201322","journal-title":"N Engl J Med"},{"issue":"2","key":"1902_CR6","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1053\/j.ajkd.2013.07.020","volume":"63","author":"J Ritchie","year":"2014","unstructured":"Ritchie J, Green D, Chrysochou C, Chalmers N, Foley RN, Kalra PA (2014) High-risk clinical presentations in atherosclerotic renovascular disease: prognosis and response to renal artery revascularization. Am J Kidney Dis 63(2):186\u2013197","journal-title":"Am J Kidney Dis"},{"key":"1902_CR7","doi-asserted-by":"publisher","unstructured":"Sens F, Normand G, Fournier T, Della-Schiava N, Luong S, Pelletier C, et al. (2019) Blood pressure decreases after revascularization in atherosclerotic renal artery disease: A cohort study based on a multidisciplinary meeting. PLoS One [Internet]. [cited 2023 Jan 7];14(6):e0218788. Available from: https:\/\/journals.plos.org\/plosone\/article?id=https:\/\/doi.org\/10.1371\/journal.pone.0218788","DOI":"10.1371\/journal.pone.0218788"},{"key":"1902_CR8","doi-asserted-by":"crossref","unstructured":"Chrysochou C, Mendichovszky IA, Buckley DL, Cheung CM, Jackson A, Kalra PA (2012) BOLD imaging: a potential predictive biomarker of renal functional outcome following revascularization in atheromatous renovascular disease. Nephrol Dialysis Transplant [Internet]. [cited 2023 Jan 8];27(3):1013\u20139. Available from: https:\/\/academic.oup.com\/ndt\/article\/27\/3\/1013\/1891790","DOI":"10.1093\/ndt\/gfr392"},{"key":"1902_CR9","doi-asserted-by":"crossref","unstructured":"Chrysochou C, Cheung CM, Durow M, Middleton RJ, Solomon LR, Craig A, et al. (2009) Proteinuria as a predictor of renal functional outcome after revascularization in atherosclerotic renovascular disease (ARVD). QJM Int J Med [Internet]. [cited 2023 Jan 8];102(4):283\u20138. Available from: https:\/\/academic.oup.com\/qjmed\/article\/102\/4\/283\/1551004","DOI":"10.1093\/qjmed\/hcp007"},{"key":"1902_CR10","doi-asserted-by":"publisher","unstructured":"Kalra PA, Chrysochou C, Green D, Cheung CM, Khavandi K, Sixt S, et al. (2010) The benefit of renal artery stenting in patients with atheromatous renovascular disease and advanced chronic kidney disease. Catheter Cardiovasc Interv [Internet]. 2010 [cited 2023 Jan 8];75(1):1\u201310. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/full\/https:\/\/doi.org\/10.1002\/ccd.22290","DOI":"10.1002\/ccd.22290"},{"key":"1902_CR11","first-page":"1956","volume":"36","author":"B Williams","year":"2018","unstructured":"Williams B, Mancia G, Spiering W, Rosei EA, Azizi M, Burnier M et al (2018) ESC\/ESHGuidelines for themanagement of arterial hypertension. J Hypertens Lippincott Williams Wilkins. 36:1956\u20132041","journal-title":"J Hypertens Lippincott Williams Wilkins."},{"issue":"6","key":"1902_CR12","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1016\/j.jacc.2005.10.009","volume":"47","author":"AT Hirsch","year":"2006","unstructured":"Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL et al (2006) ACC\/AHA 2005 Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery\/Society for vas. J Am Coll Cardiol 47(6):1239\u20131312","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"1902_CR13","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1053\/j.ajkd.2021.06.025","volume":"79","author":"CW Hicks","year":"2022","unstructured":"Hicks CW, Clark TWI, Cooper CJ, de Bhail\u00eds \u00c1M, De Carlo M, Green D et al (2022) Atherosclerotic renovascular disease: a KDIGO (Kidney disease: improving global outcomes) controversies conference. Am J Kidney Dis 79(2):289\u2013301","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"1902_CR14","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1097\/HJH.0000000000001499","volume":"36","author":"Y Iwashima","year":"2018","unstructured":"Iwashima Y, Fukuda T, Horio T, Hayashi SI, Kusunoki H, Kishida M et al (2018) Association between renal function and outcomes after percutaneous transluminal renal angioplasty in hypertensive patients with renal artery stenosis. J Hypertens 36(1):126\u2013135","journal-title":"J Hypertens"},{"key":"1902_CR15","doi-asserted-by":"publisher","unstructured":"Church S, Rogers E, Rockwood K, Theou O (2020) A scoping review of the Clinical Frailty Scale. BMC Geriatr [Internet]. [cited 2023 Oct 31];20(1):1\u201318. Available from: https:\/\/bmcgeriatr.biomedcentral.com\/articles\/https:\/\/doi.org\/10.1186\/s12877-020-01801-7","DOI":"10.1186\/s12877-020-01801-7"},{"key":"1902_CR16","unstructured":"Aboyans V, Ricco JB, Bartelink MLEL, Bj\u00f6rck M, Brodmann M, Cohnert T, et al. (2017) ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS). Eur Heart J. Oxford University Press 39:763\u2013816"},{"key":"1902_CR17","doi-asserted-by":"crossref","unstructured":"Vassallo D, Ritchie J, Green D, Chrysochou C, Kalra PA (2018) The effect of revascularization in patients with anatomically significant atherosclerotic renovascular disease presenting with high-risk clinical features. Nephrol Dialysis Transplant [Internet]. [cited 2023 Jan 15];33(3):497\u2013506. Available from: https:\/\/academic.oup.com\/ndt\/article\/33\/3\/497\/3084408","DOI":"10.1093\/ndt\/gfx025"},{"key":"1902_CR18","doi-asserted-by":"publisher","unstructured":"Reinhard M, Schousboe K, Andersen UB, Buus NH, Rantanen JM, Bech JN, et al. (2022) Renal artery stenting in consecutive high-risk patients with atherosclerotic renovascular disease: a prospective 2-center cohort study. J Am Heart Assoc [Internet]. [cited 2023 Jan 15];11(7):24421. Available from: https:\/\/www.ahajournals.org\/doi\/abs\/https:\/\/doi.org\/10.1161\/JAHA.121.024421","DOI":"10.1161\/JAHA.121.024421"},{"issue":"10285","key":"1902_CR19","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1016\/S0140-6736(21)00590-0","volume":"397","author":"A Adler","year":"2021","unstructured":"Adler A, Agodoa L, Algra A, Asselbergs FW, Beckett NS, Berge E et al (2021) Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis. The Lancet 397(10285):1625\u20131636","journal-title":"The Lancet"},{"key":"1902_CR20","doi-asserted-by":"publisher","unstructured":"Jenks S, Yeoh SE, Conway BR (2014) Balloon angioplasty, with and without stenting, versus medical therapy for hypertensive patients with renal artery stenosis. Cochrane Database Syst Rev [Internet]. [cited 2022 Oct 15];2014(12). Available from: https:\/\/www.cochranelibrary.com\/cdsr\/doi\/https:\/\/doi.org\/10.1002\/14651858.CD002944.pub2\/full","DOI":"10.1002\/14651858.CD002944.pub2\/full"},{"issue":"14","key":"1902_CR21","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1161\/01.CIR.102.14.1671","volume":"102","author":"PS Watson","year":"2000","unstructured":"Watson PS, Hadjipetrou P, Cox SV, Piemonte TC, Eisenhauer AC (2000) Effect of renal artery stenting on renal function and size in patients with atherosclerotic renovascular disease. Circulation 102(14):1671\u20131677","journal-title":"Circulation"},{"key":"1902_CR22","doi-asserted-by":"crossref","unstructured":"Kane GC, Xu N, Mistrik E, Roubicek T, Stanson AW, Garovic VD (2010) Renal artery revascularization improves heart failure control in patients with atherosclerotic renal artery stenosis. Nephrol Dialysis Transplant [Internet]. [cited 2023 Jan 7];25(3):813\u201320. Available from: https:\/\/academic.oup.com\/ndt\/article\/25\/3\/813\/1909488","DOI":"10.1093\/ndt\/gfp393"},{"key":"1902_CR23","doi-asserted-by":"crossref","unstructured":"Dregoesc MI, Bolboac\u01ce SD, Doroltan PM, Istrate M, Marc MC, Iancu AC (2021) Long-term mortality after renal artery stenting in patients with severe atherosclerotic renal artery stenosis and high-risk clinical manifestations. Am J Hypertens [Internet]. [cited 2023 Jan 7];34(8):880\u20137. Available from: https:\/\/academic.oup.com\/ajh\/article\/34\/8\/880\/6126772","DOI":"10.1093\/ajh\/hpab027"},{"key":"1902_CR24","doi-asserted-by":"publisher","unstructured":"Rocha-Singh K, Jaff MR, Rosenfield K (2005) Evaluation of the safety and effectiveness of renal artery stenting after unsuccessful balloon angioplasty: The ASPIRE-2 Study. J Am Coll Cardiol [Internet]. [cited 2023 May 21];46(5):776\u201383. Available from: https:\/\/www.jacc.org\/doi\/https:\/\/doi.org\/10.1016\/j.jacc.2004.11.073","DOI":"10.1016\/j.jacc.2004.11.073"},{"key":"1902_CR25","unstructured":"Klein AJ, Jaff MR, Gray BH, Aronow HD, Bersin RM, Diaz-Sandoval LJ, et al. SCAI appropriate use criteria for peripheral arterial interventions: an update"},{"key":"1902_CR26","doi-asserted-by":"crossref","unstructured":"Blackwood O, Deb R (2020) Multidisciplinary team approach in breast cancer care: Benefits and challenges. Vol. 63, Indian journal of pathology & microbiology. NLM (Medline). S105\u2013S112","DOI":"10.4103\/IJPM.IJPM_885_19"},{"key":"1902_CR27","doi-asserted-by":"crossref","unstructured":"Gerke AK (2020) Treatment of sarcoidosis: a multidisciplinary approach. Front Immunol Front Media 11","DOI":"10.3389\/fimmu.2020.545413"},{"key":"1902_CR28","doi-asserted-by":"crossref","unstructured":"Friedman GN, Benton JA, Echt M, De la Garza Ramos R, Shin JH, Coumans JVCE, et al. (20202) Multidisciplinary approaches to complication reduction in complex spine surgery: a systematic review. Spine J. Elsevier Inc.; 20:1248\u20131260","DOI":"10.1016\/j.spinee.2020.04.008"},{"key":"1902_CR29","doi-asserted-by":"crossref","unstructured":"Williams GJ, Macaskill P, Chan SF, Karplus TE, Yung W, Hodson EM, et al (2007) Comparative accuracy of renal duplex sonographic parameters in the diagnosis of renal artery stenosis: paired and unpaired analysis. Am J Roentgenol [Internet]. [cited 2022 Oct 15];188(3):798\u2013811. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK74460\/","DOI":"10.2214\/AJR.06.0355"},{"key":"1902_CR30","doi-asserted-by":"publisher","unstructured":"Bhalla V, Textor SC, Beckman JA, Casanegra AI, Cooper CJ, Kim ESH, et al (2022) Revascularization for renovascular disease: a scientific statement from the american heart association. Hypertension [Internet]. [cited 2023 Mar 4];79(8):E128\u201343. Available from: https:\/\/www.ahajournals.org\/doi\/abs\/https:\/\/doi.org\/10.1161\/HYP.0000000000000217","DOI":"10.1161\/HYP.0000000000000217"}],"updated-by":[{"DOI":"10.1007\/s40620-024-02044-0","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T00:00:00Z","timestamp":1722816000000}}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-024-01902-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40620-024-01902-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-024-01902-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:53:59Z","timestamp":1777564439000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/37\/4\/1093\/8306783"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,9]]},"references-count":30,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,5]]}},"alternative-id":["1902"],"URL":"https:\/\/doi.org\/10.1007\/s40620-024-01902-1","relation":{},"ISSN":["1724-6059"],"issn-type":[{"value":"1724-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,9]]},"assertion":[{"value":"15 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2024","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s40620-024-02044-0","URL":"https:\/\/doi.org\/10.1007\/s40620-024-02044-0","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study complies with the declaration of Helsinki and was registered with the Research and Innovation department of the Northern Care Alliance NHS Group (Reference Number: 22HIP25), who approved the methodological protocol as outlined above.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The article does not contain any studies with human participants or animals performed by any of the authors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights"}},{"value":"As this was a retrospective observational study using measurements routinely collected and fully anonymized data, the need for individual patient consent was waived by the Research and Innovation review committee, who granted study approval.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}